Myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.
AML relapsed again 5 months later and the patient was given chemotherapy.
2
However, there are conflicting results on the effects with other AML subtypes.
3
Results: Several biologic features of AML differ between older and younger individuals.
4
Patients and methods: We examined 178 adult patients with newly diagnosed AML.
5
In the UK, AML is governed by four Acts of primary legislation.
1
Complete remission was induced in about 80% of ANLL patients in both chemotherapies.
2
These findings underscore the heterogeneity of ANLL.
3
When the growth fraction was considered, however, ANLL proliferative activity was higher and more like that of normal BM.
4
HL-60 cells and ANLL cells were incubated with or without retinoids for 5 days.
5
As previously reported for ALL in infants, ANLL of infancy shows a similar heterogeneity regarding phenotypic and genotypic features.
1
Specific rearrangements of chromosome 16 are well known in acutenonlymphocyticleukemia with abnormal eosinophils.
2
Low-dose Ara-C may provide an alternative therapy in the selected patient with acutenonlymphocyticleukemia or a myelodysplastic syndrome.
3
Twenty-seven patients over 60 years of age with acutenonlymphocyticleukemia (ANLL) were prospectively treated with one of three intensive chemotherapeutic regimens.
4
Chromosomal studies were performed in the same laboratory on 97 untreated cases of de novo acutenonlymphocyticleukemia M2.
5
In contrast, of 12 patients with either acutenonlymphocyticleukemia or acute lymphoblastic leukemia who underwent transplantation during relapse, 11 died within 6 months.
1
A 21-year-old man with an acutemyelocyticleukemia received a bone marrow graft from a cousin mismatched for a single HLA-DR locus antigen.
1
Photo taken in 2019, just before she was diagnosed with acutemyeloidleukaemia.
2
Background: There are little data from India on the management of acutemyeloidleukaemia.
3
An autopsy later found the girl had acutemyeloidleukaemia.
4
We report a cytogenetic subgroup of acutemyeloidleukaemia whose incidence is independent of age.
5
His focus then turned towards developing novel therapeutics for paediatric and adult acutemyeloidleukaemia.
1
A 64-yr-old female developed acutemyeloblasticleukemia following radiation and drug therapy for colon carcinoma.
1
Different subtypes of acutemyelogenousleukemia have distinct clinical presentations and courses.
2
Two patients developed acutemyelogenousleukemia after completion of 3 years of GM-CSF administration.
3
Immunotherapy trials for acutemyelogenousleukemia mainly have involved adults.
4
Especially BH-AC is the first choice agent for acutemyelogenousleukemia combined with other agents.
5
No acutemyelogenousleukemia or myelodysplastic syndrome was observed.
1
The results are presented of allogeneic transplantation for 363 patients with acute non-lymphoblastic leukemia treated in Seattle from May 1973 through December 1985.
Uso de acute myeloid leukemia em inglês
1
The first patient was a 50 years woman with acutemyeloidleukemia.
2
Three cases of acutemyeloidleukemia were reported in the HEC arm.
3
They include oncology drugs for melanoma, prostate cancer and acutemyeloidleukemia.
4
Two cases of acutemyeloidleukemia were reported with the best available therapy.
5
Diseases with the poorest 6-mo prognosis were acutemyeloidleukemia and non-Hodgkin lymphoma.
6
Differentiation therapy for acutemyeloidleukemia uses transcriptional modulators to reprogram cancer cells.
7
Cutaneous myeloid sarcoma in most cases represents an aggressive manifestation of acutemyeloidleukemia.
8
Achievement of complete remission is essential for long-term survival of acutemyeloidleukemia patients.
9
Current therapies for acutemyeloidleukemia are associated with high failure and relapse rates.
10
Eight cases had history of acutemyeloidleukemia, and 3 had myeloid leukemia while pregnancy.
11
Thirteen patients had other myeloid neoplasms, of which 4 ultimately progressed to an acutemyeloidleukemia.
12
Mutations identified in acutemyeloidleukemia patients are useful for prognosis and for selecting targeted therapies.
13
The hit compounds display activity in Mnk biochemical and cellular assays, including acutemyeloidleukemia progenitors.
14
Exceedingly rare in childhood, it has more commonly been described in association with acutemyeloidleukemia.
15
Conclusion: Autocrine VEGF plays an important role in the proliferation and apoptosis of acutemyeloidleukemia cells.
16
These data suggest that Hsps could be implicated in the progression of MDS to acutemyeloidleukemia.